Vagus Nerve Stimulator in a Patient with Adenylosuccinate Lyase Deficiency: a Case Report

Abstract

Adenylosuccinate lyase deficiency (ADSL) is a rare inborn error of metabolism in which epilepsy is a common feature, and often seizures are intractable. We present the first documented case of a female patient with intractable epilepsy secondary to ADSL who had exacerbation of her seizures following implantation of a vagus nerve stimulator (VNS). In addition, using PubMed search engine, we reviewed the current literature on treatment of epilepsy associated with ADSL as well as VNS therapy in patients with epilepsy associated with inborn errors of metabolism. VNS has shown to be a safe and efficacious treatment option for patients with intractable epilepsies of various causes; however, there are no published cases of VNS in this particular syndrome. There are limited data on the efficacy of VNS in patients with epilepsy associated with inborn errors of metabolism, and further study is needed.

Keywords

vagus nerve stimulator - adenylosuccinate lyase deficiency - intractable epilepsy - inborn errors of metabolism

• References

• 1 Ciardo F, Salerno C, Curatolo P. Neurologic aspects of adenylosuccinate lyase deficiency. J Child Neurol 2001; 16 (5) 301-308
• 2 Nassogne M, Henrot B, Aubert G , et al. Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly. Brain Dev 2000; 22 (6) 383-386
• 3 Jurecka A, Opoka-Winiarska V, Rokicki D, Tylki-Szymańska A. Neurologic presentation, diagnostics, and therapeutic insights in a severe case of adenylosuccinate lyase deficiency. J Child Neurol 2012; 27 (5) 645-649
• 4 Papetti L, Parisi P, Leuzzi V , et al. Metabolic epilepsy: an update. Brain Dev 2013; 35 (9) 827-841
• 5 Gitiaux C, Ceballos-Picot I, Marie S , et al. Misleading behavioural phenotype with adenylosuccinate lyase deficiency. Eur J Hum Genet 2009; 17 (1) 133-136
• 6 Jurecka A, Zikanova M, Tylki-Szymanska A , et al. Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency. Mol Genet Metab 2008; 94 (4) 435-442
• 7 Lundy CT, Jungbluth H, Pohl KRE , et al. Adenylosuccinate lyase deficiency in the United Kingdom pediatric population: first three cases. Pediatr Neurol 2010; 43 (5) 351-354
• 8 Pérez-Dueñas B, Sempere A, Campistol J , et al. Novel features in the evolution of adenylosuccinate lyase deficiency. Eur J Paediatr Neurol 2012; 16 (4) 343-348
• 9 Terra VC, Amorim R, Silvado C , et al. Vagus nerve stimulator in patients with epilepsy: indications and recommendations for use. Arq Neuropsiquiatr 2013; 71 (11) 902-906
• 10 Hauptman JS, Mathern GW. Vagal nerve stimulation for pharmacoresistant epilepsy in children. Surg Neurol Int 2012; 3 (Suppl. 04) S269-S274
• 11 Morris III GL, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013; 81 (16) 1453-1459
• 12 Elliott RE, Rodgers SD, Bassani L , et al. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr 2011; 7 (5) 491-500
• 13 Majoie HJM, Berfelo MW, Aldenkamp AP, Renier WO, Kessels AGH. Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study. Seizure 2005; 14 (1) 10-18
• 14 Tsao C-Y. The efficacy of vagus nerve stimulation in intractable epilepsy associated with nonketotic hyperglycinemia in two children. J Child Neurol 2010; 25 (3) 375-378
• 15 Arthur TM, Saneto RP, de Menezes MS , et al. Vagus nerve stimulation in children with mitochondrial electron transport chain deficiencies. Mitochondrion 2007; 7 (4) 279-283
• 16 Koutroumanidis M, Hennessy MJ, Binnie CD, Polkey CE. Aggravation of partial epilepsy and emergence of new seizure type during treatment with VNS. Neurology 2000; 55 (6) 892-893